Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proxalutamide + ADT for High Risk Prostate Cancer
NCT05076851Phase 2Unknown
- Start
- Jun 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of proxalutamide in prostate cancer (PCa). Status: unknown.
02
Drugs
proxalutamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT05076851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05076851.